Minneapolis Heart Institute Foundation — Minneapolis, Minnesota

Minneapolis Heart Institute Foundation is a clinical research site located in Minneapolis, Minnesota, United States 55407.

Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.

Minneapolis Heart Institute Foundation has participated in 131 clinical trials with 46 currently active.

Therapeutic areas: Coronary Artery Disease, Target Vessel Failure in Saphenous Vein Grafts, Percutaneous Coronary Intervention.

Sponsors: Shanghai MicroPort Medical (Group) Co., Ltd., Global Genomics Group, LLC, Minneapolis Heart Institute Foundation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minneapolis Heart Institute Foundation?

Minneapolis Heart Institute Foundation has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minneapolis Heart Institute Foundation conducted?

Minneapolis Heart Institute Foundation has 131 clinical trials on record, with 46 currently active. Their work covers Coronary Artery Disease, Target Vessel Failure in Saphenous Vein Grafts, Percutaneous Coronary Intervention.

Is Minneapolis Heart Institute Foundation accredited by Crixeo Clinical Trials?

Minneapolis Heart Institute Foundation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minneapolis Heart Institute Foundation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.